Machuta-Fernan Shelley MD is categorized under Radiation Laboratories in Austell, GA and active since 1990.
Machuta-Fernan Shelley MD was established in 1990, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Radiation Laboratories business, which does work in the B2B market, and is classified as a Radiation Laboratories, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Shelley Machuta-Fernan at the company’s single location by writing to 1800 Hospital South Drive, Austell, Georgia GA 30106 or by phoning (770) 751-0521. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Machuta-Fernan Shelley MD |
Contact Person: | Shelley Machuta-Fernan |
Address: | 1800 Hospital South Drive, Austell, Georgia 30106 |
Phone Number: | (770) 751-0521 |
Website Address: | radonc.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1990 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Radiation Laboratories |
SIC Code: | 8734 |
NAICS Code: | 6211110 |
Share This Business: |
Machuta-Fernan Shelley MD was started in 1990 to provide professional Radiation Laboratories under the SIC code 8734 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Shelley Machuta-Fernan for inquiries that concern Machuta-Fernan Shelley MD by calling the company number (770) 751-0521, as your correspondence is most welcome. Additionally, the physical location of the single location of Machuta-Fernan Shelley MD can be found at the coordinates 33.85612,-84.6049 as well as the street address 1800 Hospital South Drive in Austell, Georgia 30106.
For its online presence, you may visit Machuta-Fernan Shelley MD’s website at radonc.com and engage with its social media outlets through on Twitter and on Facebook.